drugset / Trial / NCT05203315
Investigator Initiated Trial to Study Duobrii® Lotion in the Treatment of Mild Plaque Psoriasis in Adults
RandomizedSingle-groupOpen-labelTreatment
Summary
This study seeks to evaluate the safety, tolerability, and efficacy of topical Duobrii® Lotion in adult subjects with mild plaque psoriasis.
Timeline
- Start
- 2022-01-13
- Primary completion
- 2023-10-04
- Completion
- 2023-10-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tazarotene | Small molecule | 0.045 % | Topical |
| Subject | halobetasol propionate | Small molecule | 0.01 % | Topical |